TARDITO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.492
EU - Europa 906
AS - Asia 344
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 3
SA - Sud America 1
Totale 5.767
Nazione #
US - Stati Uniti d'America 4.432
DE - Germania 226
UA - Ucraina 202
CN - Cina 154
SE - Svezia 125
SG - Singapore 124
GB - Regno Unito 87
IE - Irlanda 69
IT - Italia 63
CA - Canada 56
FI - Finlandia 51
TR - Turchia 50
RU - Federazione Russa 47
EU - Europa 21
PL - Polonia 13
FR - Francia 12
IL - Israele 11
BE - Belgio 8
IN - India 3
MX - Messico 3
SC - Seychelles 2
AL - Albania 1
EC - Ecuador 1
EG - Egitto 1
GL - Groenlandia 1
IR - Iran 1
NL - Olanda 1
SI - Slovenia 1
TW - Taiwan 1
Totale 5.767
Città #
Fairfield 791
Chandler 506
Woodbridge 383
Ashburn 336
Seattle 326
Jacksonville 315
Cambridge 285
Houston 281
Wilmington 279
Ann Arbor 156
Beijing 115
Lawrence 70
Princeton 69
Dublin 68
New York 66
Ottawa 56
Boardman 48
Helsinki 45
London 39
Singapore 38
San Diego 29
Hefei 15
West Jordan 14
Kraków 13
Kursk 10
Milan 10
Redwood City 10
St Louis 10
Chiswick 9
Prescot 9
Brussels 8
Nanjing 5
Falls Church 4
Guangzhou 4
Rome 4
Brescia 3
Dearborn 3
Islington 3
Mexico City 3
Norwalk 3
Sotto 3
Chicago 2
Hounslow 2
Jinan 2
Kilburn 2
Nanchang 2
New Bedfont 2
Redmond 2
Segrate 2
Shanghai 2
Azzano San Paolo 1
Bari 1
Berlin 1
Bologna 1
Cairo 1
Calusco D'adda 1
Cascina 1
Cedar Knolls 1
Falkenstein 1
Giussano 1
Greenville 1
Groningen 1
Guiyang 1
Hebei 1
Jinhua 1
Kunming 1
Lappeenranta 1
Ljubljana 1
Los Angeles 1
Mapello 1
Miami Beach 1
Monza 1
New Delhi 1
Nuuk 1
Paris 1
Piacenza 1
Pune 1
Quito 1
Quzhou 1
Ruvo Di Puglia 1
San Giuseppe Vesuviano 1
Santa Clara 1
Secaucus 1
Shenyang 1
Taipei 1
Tappahannock 1
Tirana 1
Treviso 1
Wandsworth 1
Washington 1
Wuhan 1
Yoshkar-ola 1
Zhengzhou 1
Zhoushan 1
Totale 4.506
Nome #
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 227
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 191
Physical Exercise and Antidepressants Enhance BDNF Targeting in Hippocampal CA3 Dendrites : Further Evidence of a Spatial Code for BDNF Splice Variants 185
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 163
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 162
Blood microRNA changes in depressed patients during antidepressant treatment 146
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 144
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia 142
Molecular neuroplasticity in mood disorders and drug action: lessons front a gene X environment model 142
Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder 139
Implications of the cAMP signaling pathway in psychiatric disorders: a systematic review of the evidence 133
Expression and phosphorylation of δ-CaM kinase II in cultured Alzheimer fibroblasts 126
Synaptoproteomics of Existing and new Animal Models of Depression 126
Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment 124
Global epigenetic analysis of BDNF Val66Met mice hippocampus reveals changes in dendrite and spine remodeling genes 117
Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus 113
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine 113
Effects of lithium on cAMP-dependent protein kinase in rat brain 105
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 104
Agomelatine and fluoxetine treatments induce different and time-dependent modulation of rat hippocampal miRNome 98
Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants 95
Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants 95
Early and time-dependent modulation of rat hippocampal miRNome during treatment with agomelatine 93
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 93
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 89
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 88
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants : a critical overview 88
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 87
Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression 86
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs 86
Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder 82
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression 82
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors 81
Synergistic mechanisms involved in the antidepressant effects of agomelatine 77
Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells 77
Early induction of CREB activation and CREB-regulating signalling by antidepressants 77
Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades 75
Protein kinase A and Rap1 levels in platelets of untreated patients with major depression 71
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors 69
Synergy between melatonergic and 5-HT2C receptors in the action of agomelatine : molecular and cellular evidence 68
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs 66
Lithium effects on basal and stimulated CREB phosphorylation in SH-SY5Y cells: a bimodal action on CaMKIV and Erk1/2 64
cAMP signaling pathway in depressed patients with psychotic features 62
Agomelatine Treatment Induces Early and Time- dependent Modulation of Rat Hippocampal MiRNome 62
Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder 61
TIME-DEPENDENT EFFECTS OF ANTIDEPRESSANT TREATMENTS ON MIRNOME EXPRESSION PROFILE IN HIPPOCAMPUS OF RATS 60
The interface between depression and cerebrovascular disease--some hope but no hype 59
Biologia dei citocromi P450: caratteristiche generali 59
Depressione, attivazione piastrinica e malattie cardiovascolari 57
Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments 55
Epigenetic analysis reveals selective impairment of bdnf-6 expression and dendritic translocation in BDNF Val66Met transgenic mice 53
Psicofarmacologia clinica 53
Protein kinase A activity in platelets from patients with bipolar disorder 51
Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment 51
Psicofarmacologia clinica 48
Trattamento dei disturbi da uso di sostanze 47
Implications of cAMP signaling in affective disorders: new answers more questions 47
Chronic Antidepressants Induce Redistribution and Differential Activation of αCaM Kinase II between Presynaptic Compartments 47
The action of stress on depolarization-evoked release of glutamate and the protective effect of antidepressants 47
Long-term soluble Aβ1–40 activates CaM kinase II in organotypic hippocampal cultures 45
I citocromi P450. Dalla biologia alla terapia 43
Amisulpride 39
The protein kinase A in platelets from patients with panic disorder 38
[Implications of cAMP signaling in affective disorders] 33
Reboxetina 29
Implicaciones de la señal AMPc en los trastornos afectivos 28
Time in the brain : rythms of intercellular and intracellular processes 28
Inibitori reversibili delle MAO-A (RIMA) 26
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 17
null 10
null 1
Totale 5.845
Categoria #
all - tutte 35.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.280 0 0 45 133 14 232 169 207 169 193 54 64
2020/20212.067 111 146 294 408 168 283 208 112 100 38 149 50
2021/2022483 69 44 89 56 3 34 26 104 21 21 13 3
2022/20231.301 141 51 39 177 105 269 1 165 227 34 70 22
2023/2024421 18 30 47 40 54 75 9 8 0 17 9 114
2024/202541 24 13 4 0 0 0 0 0 0 0 0 0
Totale 5.845